Barclays PLC Decibel Therapeutics, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023
SELL
$2.08 - $4.79 $473,869 - $1.09 Million
-227,822 Reduced 95.45%
10,855 $33,000
Q4 2022

Feb 13, 2023
SELL
$1.86 - $3.54 $1,488 - $2,832
-800 Reduced 0.33%
238,677 $489,000
Q2 2022

Aug 12, 2022
SELL
$1.85 - $4.21 $1,591 - $3,620
-860 Reduced 0.36%
239,477 $1.01 Million
Q1 2022

May 16, 2022
BUY
$2.83 - $5.03 $680,153 - $1.21 Million
240,337 New
240,337 $731,000

About Decibel Therapeutics, Inc.

DBTX Quotes by TradingView
  • Ticker DBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,964,500
  • Description
  • Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...
More about DBTX
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email